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Original Article
Exogenous administration of lipids to
steers alters aspects of the innate immune
response to endotoxin challenge
Nicole C Burdick Sanchez1, Jeffery A Carroll1,
Janet R Donaldson2, Joe O Buntyn3 and Ty B Schmidt3
Abstract
This study examined the effects of increasing energy availability from both dextrose and lipid treatments on the pro-
inflammatory response to LPS in Holstein steers. Steers were randomly assigned to one of three groups: saline at 0.5ml/
kg body weight (Control) or 50% dextrose [0.5ml/kg body weight (Dextrose) to mimic calm cattle’s response to LPS]
administered immediately prior to LPS (0.5 mg/kg body weight at 0 h) or continuous lipid emulsion infusion from 1 to
6 h [Intralipid 20% (Baxter, Deerfield, IL USA); 0.5ml/kg/hr (Lipid) to mimic temperamental cattle]. Concentrations of
non-esterified fatty acids (NEFA) were greater in Lipid compared with Control and Dextrose steers. A greater decrease
in the change in rectal temperature, relative to baseline, was observed in response to LPS in Dextrose in comparison to
control and Lipid steers. Cortisol was greater in Lipid than Dextrose and Control steers from 0.5 to 0 h, yet decreased
from 0.5 to 5.5 h relative to LPS challenge. Concentrations of IL-6 were decreased in Lipid steers compared with
Dextrose and Control steers, and were decreased in Dextrose compared with Control steers post-LPS challenge.
These data suggest that increasing circulating NEFA using an exogenous Lipid emulsion may modulate the pro-inflam-
matory response in steers.
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Introduction
In order to provide the necessary energy required for an
activated and functional immune system, energy
requirements of the body are shifted through changes
in metabolism and energy redistribution. Specifically,
Kluger and Rothenburg reported that a 10–13%
increase in metabolizable energy is required to increase
body temperature 1C.1 This increased energy require-
ment does not account for the energy necessary for
other actions of the immune system, including antibody
and acute phase protein production. Therefore, the
immune response is very energy demanding, which
can lead to the down-regulation of non-essential sys-
tems that are not as essential for the immediate survival
of the animal, such as reproduction or growth. This
redistribution of energy to the immune response and
away from reproduction and growth can ultimately
influence production efficiency and thus production
costs.
Natural variations, such as sex, breed and tempera-
ment, can influence metabolic responses in cattle. In
particular, temperamental cattle naturally may require
more energy for normal maintenance due to their ‘high
strung’ nature, perhaps due to alterations in glucose
uptake and utilization, and gluconeogenesis. We previ-
ously reported differences in the metabolic response to
a LPS (endotoxin) challenge in calm versus tempera-
mental beef bulls.2 Specifically, cattle classified as
temperamental maintained elevated ( 0.40mmol/l)
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non-esterified fatty acid (NEFA) concentrations prior
to and throughout the LPS challenge period compared
with calm bulls.2 The increased NEFA concentrations
suggest that the temperamental cattle are in a negative
energy balance, which is inaccurate as cattle in this
study were fed ad libitum. In contrast, calm bulls pro-
duced the greatest glucose response to the LPS chal-
lenge compared with temperamental bulls, while there
was no increase in glucose concentrations post-LPS in
temperamental bulls. These data suggest that the
altered metabolic parameters observed between calm
and temperamental bulls may have influenced the dif-
ferences in the physiological and innate immune
responses (i.e. decreased rectal temperature, sickness
behavior and stress hormone responses) to LPS
observed in these same bulls.3 Moreover, we hypothe-
size that metabolic alterations that result in greater
energy availability may provide an immunostimulatory
or immunoprotective function while providing an
energy-dense source to be accessible to the immune
system upon pathogen exposure and immune system
activation.
Preliminary unpublished data from our laboratory
have demonstrated that a continuous infusion of a
Lipid emulsion (Intralipid 20%; Baxter, Deerfield, IL
USA) can increase serum NEFA concentrations in
dairy steers fed ad libitum to values similar to those
observed in temperamental beef bulls (i.e. 0.4mmol/
l). Based on previously observed changes in the meta-
bolic and innate immune responses in temperamental
bulls, the objective of this study was to determine if
increasing energy availability through either a continu-
ous Intralipid infusion (to mimic temperamental bulls)
or through a bolus injection of Dextrose (to mimic calm
bulls response to LPS) would alter the innate immune
response following a LPS challenge.
Materials and methods
Experimental design
All experimental procedures were carried out in com-
pliance with the Guide for the Care and Use of
Agricultural Animals in Research and Teaching and
approved by the Institutional Animal Care and Use
Committee at Mississippi State University.
Holstein steers (n¼ 21; 165 5 kg body weight) were
acquired from a local dairy farm and transported to the
Mississippi State University Beef Center. Upon arrival,
steers were randomly assigned to one of three treatments
(n¼ 7 per treatment): (1) administered 0.5ml/kg body
weight saline immediately prior to LPS challenge at 0 h
(Control); (2) administered 0.5ml/kg body weight 50%
dextrose solution immediately prior to LPS challenge at
0 h (Dextrose); or (3) continuous infusion of a Lipid
emulsion (Intralipid 20%; Baxter) at a rate of 0.5ml/
kg/hr from 1 to 6 h relative to LPS challenge at 0 h
(Lipid). The doses of dextrose and Intralipid were
selected to increase peak post-LPS glucose concentra-
tion, and pre- and post-LPS NEFA concentrations to
values similar to those previously reported for calm and
temperamental bulls pre- and post-LPS.2
On d 1, steers were fitted with indwelling jugular vein
cannulas and indwelling rectal temperature (RT)
probes that recorded RT at 1-min intervals throughout
the duration of the study.2,4 Folldue these procedures
steers were placed in tie stalls for the remainder of the
study. On d 0, blood samples (9ml) were collected into
Sarstedt tubes (Sarstedt Inc., Newton, NC, USA) con-
taining no additive every 30min beginning at 2 h and
continuing to 8 h after administration of LPS at 0 h
(0.5 mg/kg body weight LPS from Escherichia coli
O111:B4; Sigma Aldrich, St. Louis, MO, USA).
Blood samples were allowed to clot for 30min at
room temperature and were then centrifuged at 1500 g
for 20min at 4C. Isolated serum was stored at 80C
until analyzed for NEFA, glucose, cortisol and cyto-
kine concentrations.
Serum analysis
All serum analyses were performed in duplicate.
Concentrations of NEFA were determined by modifi-
cation of the enzymatic HR Series NEFA-HR (2) assay
(Wako Diagnostics, Richmond, VA, USA) to fit a 96-
well format. Briefly, 200 ml of prepared Color Reagent
A were added to 5 ml of serum or prepared standards in
a 96-well plate. Plates were incubated at 37C for 5min
and the absorbance read using a spectrophotometer at
505 nm (Powerwave 340; BioTek, Winooski, VT,
USA). Next, 100ml of prepared Color Reagent B was
added to all wells on the 96-well plate. Plates were
incubated for an additional 5min and read for a
second time using a plate reader at 505 nm.
Concentrations of NEFA were determined by compar-
ing unknown samples to at standard curve of known
NEFA concentrations. The minimum detectable con-
centration was 0.0014 mmol/l, and the intra- and
inter-assay coefficients of variation were 6.7% and
9.2%, respectively. Data are presented as the concen-
tration in mmol/l.
Glucose concentrations were determined by modifi-
cation of the enzymatic Autokit Glucose (Wako
Diagnostics) to fit a 96-well format. Briefly, 300 ml of
prepared working solution was added to 2 ml of serum
or prepared standards in a 96-well plate. Plates were
incubated at 37C for 5min and then read using a
plate reader at 505 nm. The concentration of glucose
was determined by comparing unknown samples with
a standard curve of known glucose concentrations. The
minimum detectable concentration was 3.8 mg/dl, and
the intra- and inter-assay coefficients of variation were
7.7% and 10.8%, respectively. Data are presented as
the concentration in mg/dl.
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Serum concentrations of cortisol were determined by
enzyme immunoassay using a commercially available
kit according to the manufacturer’s instructions
(Arbor Assays, Ann Arbor, MI, USA). Serum concen-
trations of cortisol were determined by comparison
with a standard curve of known cortisol concentra-
tions. The minimum detectable concentration was
45.4 pg/ml, and intra- and inter-assay coefficients of
variation were 9.1% and 20.1%, respectively. Data
are presented as the concentration in ng/ml.
Serum cytokine concentrations (TNF-a, IFN-g and
IL-6) were determined by a custom bovine 3-plex sand-
wich-based chemiluminescence ELISA kit (Searchlight-
Aushon BioSystems Inc., Billerica, MA, USA). The
minimum detectable concentrations were 0.5, 0.1 and
3.3 pg/ml for TNF-a, IFN-g and IL-6, respectively. All
intra-assay coefficients of variation were < 11% and all
inter-assay coefficients of variation were < 22% for
all assays. Data are presented as the concentration in
pg/ml.
Statistical analysis
Prior to analysis, RT data were averaged into 5-min
intervals. Data were tested for normality of the resi-
duals by evaluating the Shapiro-Wilk statistic using
the UNIVARIATE procedure in SAS (SAS Institute,
Cary, NC, USA). Data were analyzed by the MIXED
procedure of SAS specific for repeated measures.
Treatment, time and the treatment time interaction
were included as fixed effects, with steer within treat-
ment included as the experimental unit. If treatment or
the treatment time interaction were significant
(P 0.05), data were further analyzed separately in
three different time periods: Baseline—time period
prior to application of treatments (3 h to 1 h);
Infusion—time period prior to the LPS challenge
when Lipid steers began receiving Intralipid (1 h to
0 h); and LPS Challenge—time period following admin-
istration of LPS (0–8 h). Due to differences in baseline,
RT data were analyzed as the change in RT relative to
baseline (3 h to 1 h) values, with average baseline
RT values included as a covariate. When main effects
were significant, specific treatment comparisons were
made using the PDIFF option in SAS, with P 0.05
considered significant and 0.05<P 0.10 considered a
tendency. All data are presented as the least squares
mean (LSM) SEM.
Results
Serum NEFA concentrations
There was a treatment (P< 0.01), time (P< 0.01) and a
treatment time interaction (P< 0.01) for serum
NEFA concentrations (Figure 1). Concentrations of
NEFA increased (P¼ 0.01) in the Lipid steers at
0.5 h pre-LPS challenge and remained elevated
through the duration of the study (8 h; P< 0.01) com-
pared with baseline. These concentrations were also
greater (P 0.02) than Control and Dextrose steers
from 0.5 h pre-challenge through 6 h (P< 0.01) post-
challenge, which coincided with the infusion of
Intralipid (from 1 h to 6 h). Due to the significant
treatment and treatment time interaction, the data
were further analyzed in time periods.
Prior to infusion of the Intralipid there was no differ-
ence between the three groups (treatment: P¼ 0.16;
treatment time interaction: P¼ 0.11) for serum
NEFA concentrations. However, NEFA concentrations
increased (P< 0.01) over time in all three groups. A
treatment time interaction was observed during the
Infusion period (P< 0.01). Specifically, NEFA concen-
trations were greater (P< 0.01) in Lipid steers compared
with Control and Dextrose steers from -0.5 h to 0 h
during the Infusion period. In response to LPS admin-
istration at time 0 h, a treatment time interaction
(P< 0.01) for NEFA concentrations was observed.
Similar to the Infusion period, NEFA concentrations
were greater (P< 0.01) in Lipid steers than Control
and Dextrose steers from 0 h to 6 h post-challenge.
Serum Glucose concentrations
There was no treatment effect (P¼ 0.30) or treat-
ment time interaction (P¼ 0.50) for serum glucose
concentrations (Figure 2). There was a time effect
(P< 0.01), with glucose concentrations increasing
(P< 0.01) at 0.5 h (compared with 0 h) and remaining
elevated through 5 h post-challenge (P 0.04 compared
with 0 h). At 6 h post-challenge, Glucose concentrations
decreased below 0-hr values and remained suppressed
for the remainder of the study (P 0.05).
Rectal temperature
During the Baseline period (180 to 60min) there
were effects of treatment (P< 0.01) and time
(P< 0.01), but no treatment time interaction
(P¼ 1.00) for RT. Lipid steers (39.30 0.01C) had
greater (P< 0.01) Baseline RT than Dextrose
(39.20 0.01C) and Control steers (39.18 0.01C).
Additionally, Dextrose steers had greater Baseline RT
than Control steers (P< 0.01).
Due to the treatment differences in RT values during
the Baseline period, the Infusion and LPS Challenge
periods were analyzed as the change in RT relative to
average Baseline RT values (Figure 3). During the
Infusion period, there was no effect of treatment
(P¼ 0.23), time (P¼ 0.35) or a treatment time inter-
action (P¼ 1.00) for the change in RT relative to
Baseline values (Figure 3). However, Baseline values,
included as a covariate, did account for a significant
amount of variation in the model (P¼ 0.02).
514 Innate Immunity 21(5)
  
0.6
0.5
0.4
0.3
0.2
0.1
0
-4 -2 0 2 4 6 8
Control
Dextrose
Lipid
N
EF
A 
(m
mo
l/L
)
Time Relative to LPS Challenge (h)
Figure 1. Effect of saline (0.5ml/kg; Control) or Dextrose bolus injection (0.5ml/kg; Dextrose) immediately prior to LPS (0.5 mg/kg
body weight at 0 h) administration, or continuous infusion of a Lipid emulsion (Intralipid 20%, 0.5ml/kg/hr; Lipid) from 1 h to 6 h on
serum concentrations of NEFA (Control n¼ 7, Dextrose n¼ 7, Lipid n¼ 7). Data are presented as the LSM SEM. *P< 0.01 Lipid
differs from Control and Dextrose steers.
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Figure 2. Effect of saline (0.5ml/kg; Control) or Dextrose bolus injection (0.5ml/kg; Dextrose) immediately prior to LPS (0.5 mg/kg
body weight at 0 h) administration, or continuous infusion of a lipid emulsion (Intralipid 20%, 0.5ml/kg/hr; Lipid) from 1 h to 6 h on
serum concentrations of glucose (Control n¼ 7, Dextrose n¼ 7, Lipid n¼ 7). Data are presented as the LSM SEM.
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In response to the LPS challenge, there were effects
of treatment (P¼ 0.01) and time (P< 0.01), but no
treatment time interaction (P¼ 1.00) on the change
in RT relative to Baseline values. Dextrose steers
(0.031 0.007C) had a greater (P 0.02) decrease
in RT post-LPS compared with Lipid
(0.007 0.007C) and Control steers
(0.003 0.007C). There was no difference in the
change in RT following LPS challenge between
Control and Lipid steers (P¼ 0.68). Additionally,
Baseline RT values, included as a covariate, accounted
for a significant amount of variation in the model fol-
lowing LPS administration (P< 0.01).
Serum cortisol concentrations
Treatment (P¼ 0.03) and time (P< 0.01) effects and a
treatment time interaction (P< 0.01) were observed
for serum cortisol concentrations; therefore, the data
were further analyzed by time periods. Baseline serum
cortisol concentrations were similar between the three
treatment groups (P¼ 0.54) and were not affected by a
treatment time interaction (P¼ 0.41), but were
affected by time (P¼ 0.02; Figure 4). During the
Infusion period, there was an effect of treatment
(P¼ 0.01), and a tendency (P¼ 0.06) for a treat-
ment time interaction, but there was no effect of
time (P¼ 0.13). Specifically, concentrations of cortisol
were greater in Lipid steers than Control and
Dextrose steers (P 0.03) at 0.5 h and 0 h. In the
LPS challenge period, there was a treatment time
interaction (P< 0.01) for serum cortisol concentra-
tions. Cortisol concentrations were decreased
(P 0.04) in Lipid steers compared with Control and
Dextrose steers from 4.5 h to 5.5 h, and Lipid steers
had decreased (P¼ 0.03) cortisol compared with
Dextrose steers at 6.5 h after LPS administration.
Serum cytokine concentrations
Serum concentrations of TNF-a were not affected by
treatment (P¼ 0.24) or by a treatment time inter-
action (P¼ 0.99), but were affected by time (P< 0.01;
Figure 5A). Specifically, concentrations of TNF-a
increased (P< 0.01) 1 h after LPS administration com-
pared with time 0 h values, and remained elevated
through 2.5 h post-challenge (P¼ 0.01) before returning
to Baseline values.
Similar to TNF-a, there was a main effect of time
(P< 0.01), but there was no effect of treatment
(P¼ 0.78) or a treatment time interaction (P¼ 0.99)
for serum IFN-g concentrations (Figure 5B).
Concentrations of IFN-g increased (P< 0.01) begin-
ning at 3 h post-challenge (compared with 0 h) and
remained elevated through 7.5 h post-challenge
(P¼ 0.04).
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Figure 3. Effect of saline (0.5ml/kg; Control) or Dextrose bolus injection (0.5ml/kg; Dextrose) immediately prior to LPS (0.5 mg/kg
body weight at 0 h) administration, or continuous infusion of a lipid emulsion (Intralipid 20%, 0.5ml/kg/hr; Lipid) from 1 h to 6 h on
the change in RT relative to baseline values (3 h to 1 h; Control n¼ 7, Dextrose n¼ 7, Lipid n¼ 7). Data are presented as the
LSM SEM.
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A treatment time interaction was observed for
serum concentrations of IL-6 (P¼ 0.02). Specifically,
all three treatment groups differed (P 0.05) from
each other at 4.5 h. Control steers had greater
(P 0.05) IL-6 concentrations than Dextrose and
Lipid steers at 2.5 h and 3.5 h, Control steers had greater
IL-6 concentrations thanDextrose steers from 5h to 7 h,
and Control steers had greater IL-6 than Lipid steers at
2.0, 4.0, 7.5 and 8 h relative to LPS administration at 0 h
(Figure 5C). Due to the significant treatment time
interaction, the data were further analyzed by time per-
iods. Baseline serum concentrations of IL-6 were
affected by treatment (P¼ 0.01), but not time
(P¼ 0.23) or treatment time (P¼ 0.47).
Concentrations of IL-6 were greater (P< 0.01) in
Dextrose (48.0 8.2 pg/ml) compared with Control
(1.7 7.5 pg/ml) and Lipid steers (12.7 8.8 pg/ml).
There was no difference in Baseline IL-6 concentrations
between Control and Lipid steers (P¼ 0.34). Due to the
very low Baseline IL-6 concentrations during the
Baseline period and very high post-LPS concentrations
of IL-6, absolute values of IL-6 were used for the IL-6
analyses for the Infusion and LPS Challenge periods
despite a significant treatment effect on IL-6 concentra-
tions during the Baseline period. During the Infusion
period, IL-6 concentrations were not affected by time
(P¼ 0.51) or by a treatment time interaction
(P¼ 0.68), but there was a tendency (P¼ 0.08) for a
treatment effect. Specifically, IL-6 concentrations were
greater in Dextrose steers (9.9 2.8 pg/ml) than Control
steers (2.2 2.1 pg/ml; P¼ 0.03). There was no differ-
ence in IL-6 concentrations between Control and Lipid
steers (6.8 2.3 pg/ml; P¼ 0.13) or between Dextrose
and Lipid steers (P¼ 0.41) during the Infusion period.
In response to LPS administration, IL-6 concentrations
were affected by treatment (P< 0.01) and time
(P< 0.01), but there was no treatment time interaction
(P¼ 0.39). Concentrations of IL-6 increased (P¼ 0.01)
at 1.5 h post-LPS administration, and remained elevated
for the remainder of the study. Post-LPS concentrations
of IL-6 were greater (P 0.03) in Control steers
(4289 197 pg/ml) than Dextrose (2762 197 pg/ml)
and Lipid steers (1214 212 pg/ml). Additionally,
Dextrose steers had greater IL-6 concentrations post-
LPS than Lipid steers (P< 0.01).
Discussion
The distribution and utilization of energy stores during
an immune response can greatly affect the outcome and
subsequent recovery of an animal from an immune
challenge. We have hypothesized that increasing avail-
able energy for use by the immune system before and/or
during an immune challenge may enhance recovery (i.e.
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Figure 4. Effect of saline (0.5ml/kg; Control) or Dextrose bolus injection (0.5ml/kg; Dextrose) immediately prior to LPS (0.5 mg/kg
body weight at 0 h) administration, or continuous infusion of a lipid emulsion (Intralipid 20%, 0.5ml/kg/hr; Lipid) from 1 h to 6 h on
serum concentrations of cortisol (Control n¼ 7, Dextrose n¼ 7, Lipid n¼ 7). Data are presented as the LSM SEM. **P 0.04 Lipid
differs from Control and Dextrose steers; *P¼ 0.03 Lipid differs from Dextrose steers.
Burdick Sanchez et al. 517
 
post-challenge feed intake and weight gain). The pre-
sent study tested the hypothesis that increasing avail-
able energy through a continuous Lipid emulsion
(Intralipid) or a Dextrose bolus would influence the
immune response to an LPS challenge. Results from
this study indicate that increasing available energy
prior to an immune challenge can alter aspects of
both the physiological and acute-phase responses to
LPS, which may influence post-challenge recovery and
performance.
An increase in NEFA concentrations, as a result of
adipose tissue breakdown, is typical in response to an
immune challenge. Increasing concentrations of both
NEFA and protein are needed to supply fuel for gluco-
neogenesis once glycogen stores in the liver and muscle
are depleted. Catabolism of adipose and muscle tissue is
stimulated by catabolic hormones such as cortisol, as
well as pro-inflammatory cytokines. Non-esterified
fatty acids (NEFA) released from adipose tissue can be
used as a direct energy source by tissues through the b-
oxidation process, and can also be used as a substrate to
produce more glucose through gluconeogenesis.
Infusion of Intralipid was able to increase NEFA
concentrations comparable with those previously
observed in temperamental beef bulls.2 Greater
circulating NEFA concentrations observed in
temperamental bulls have been suggested to alter the
pro-inflammatory response to endotoxemia.2,3 In the
present study, concentrations of NEFA remained ele-
vated in Lipid steers and did not appear to be influ-
enced by LPS administration at 0 h as compared with
Dextrose and Control steers. This is one of the first
studies to demonstrate that infusion of Intralipid can
increase serum concentrations of NEFAs in dairy
steers. It is important to stress that these steers were
fed ad libitum and therefore were in a positive energy
balance, as NEFA concentrations attained in this study
are typical in cattle in a negative energy balance.
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Figure 5. Effect of saline (0.5ml/kg; Control) or dextrose bolus injection (0.5ml/kg; Dextrose) immediately prior to LPS (0.5 mg/kg
body weight at 0 h) administration, or continuous infusion of a lipid emulsion (Intralipid 20%, 0.5ml/kg/hr; Lipid) from 1 h to 6 h on
serum concentrations of cytokines. (A) TNF-a; (B) IFN-g; (C) IL-6 (Control n¼ 7, Dextrose n¼ 7, Lipid n¼ 7). Data are presented as
the LSM SEM. ***P 0.05 all three treatment groups differ; **P 0.05 Control differs from Dextrose and Lipid treatments; *P 0.03
Control and Dextrose treatments differ from Lipid; #P 0.01 Control differs from Lipid treatment.
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Administration of a glucose bolus prior to administra-
tion of LPS did not appear to influence post-LPS
NEFA concentrations, as NEFA concentrations were
similar between Control and Dextrose steers.
Infusion of Intralipid did not alter glucose concen-
trations prior to LPS administration. Interestingly,
administration of a Dextrose bolus prior to administra-
tion of LPS did not influence peak glucose concen-
trations following LPS administration. Therefore, the
difference in glucose concentrations due to tempera-
ment observed previously between calm and tempera-
mental bulls was not replicated in the current study
by direct infusion of a Dextrose bolus immediately
prior to LPS administration.2 It is possible that the
bolus dose of Dextrose administered to Dextrose
steers prevented or inhibited any additional release of
glucose from glycogen stores in the liver and muscle,
thus preventing a greater peak in glucose concentra-
tions post-LPS.
Other parameters (i.e. body temperature, stress hor-
mones and cytokines) increase rapidly in response to
endotoxin challenge, including components of the
pro-inflammatory immune response. The measurement
of body temperature is typically used to verify that ani-
mals are ill. However, various management techniques,
as well as an animal’s temperament, can increase rectal
and vaginal temperature in the absence of an infection.3
In the current study, Baseline RT was greater in Lipid
compared to Dextrose and Control steers. This differ-
ence could be due to previous handling, animal tem-
perament or to randomization without stratification
of previous RT measurements; however, it is impossible
to determine the exact cause for the difference as
Baseline RT was measured for only a short period of
time (2 h) prior to the initiation of Intralipid infusion.
Folldue administration of LPS, the change in RT was
decreased in Dextrose compared with Control and
Lipid steers. This is in contrast to what was observed
in calm bulls, which had greater RT responses com-
pared with Baseline values.3 In humans, an increase
in glucose has been linked to decreased core body tem-
perature;5,6 however, no similar data in cattle are avail-
able. Additionally, the aforementioned studies were
performed in the absence of an inflammatory stimulus
as in the current study. Therefore, additional research is
necessary in cattle to determine if there is a link
between glucose concentrations and the RT response
to a LPS challenge.
Changes in stress hormones and cytokines define
the early pro-inflammatory response to a pathogen.
An increase in cortisol is one of the first endocrine
changes observed in response to LPS challenge, occur-
ring prior to detectable increases in cytokines.7 In this
manner, the early release of cortisol serves to prime
and stimulate the pro-inflammatory response, while
the extended elevation of cortisol over time leads to
the down-regulation of the pro-inflammatory response
(i.e. pro-inflammatory cytokines TNF-a, IFN-g and
IL-6) and stimulation of the production of anti-
inflammatory cytokines (i.e. IL-2, IL-4 and IL-10).8
Therefore, cortisol is a critical component in the regu-
lation of the pro-inflammatory response such that it
prevents a hyper-inflammatory state, which can be
detrimental to the health and recovery of the animal.
infusion of Intralipid prior to administration of LPS
increased cortisol concentrations in comparison with
Dextrose and Control steers. This is interesting due to
the fact that temperamental cattle have been observed
to have greater basal cortisol concentrations.3,9
Therefore, this suggests a strong relationship between
cortisol and NEFA concentrations. This response was
expected, as cortisol increases lipolysis and circulating
NEFA concentrations. However, in the current study
the roles were reversed, with increases in cortisol
observed in response to an increase in NEFA concen-
trations. There are very few studies in which cortisol
was measured during an Intralipid infusion, with no
studies found using cattle models. Studies in humans
have suggested that infusion of Intralipid either had
no effect or decreased cortisol concentrations.10–12
However, many of these studies were performed
under systems that maintained insulin and/or glucose
concentrations at predetermined concentrations. Yet,
Intralipid infusion in humans did not appear to influ-
ence whole-body cortisol metabolism, but did increase
conversion of cortisone to cortisol in subcutaneous
adipose tissue.13 In contrast to the studies in
humans, studies in rodents have observed increases
in both adrenocorticotropic hormone (ACTH), as
well as corticosterone following administration of
Intralipid, supporting the results observed in the cur-
rent study in cattle.14,15 However, the rodent studies
also found increases in glucose in response to
Intralipid infusion, which is contrary to what was
observed in the current study.15 The current study is
the first study in cattle to demonstrate a relationship
between elevated NEFA concentrations due to a con-
tinuous Intralipid infusion and cortisol concentrations,
and demonstrates the need for further research on the
relationship between Intralipid-induced increases in
NEFA concentrations and cortisol in cattle.
The cortisol response following LPS administration
was decreased in the Lipid treatment compared with
Control and Dextrose treatments. This suggests that
the greater cortisol concentrations prior to administra-
tion of LPS blunted the LPS-stimulated cortisol
response. This is similar to what has been observed in
temperamental bulls, where greater basal cortisol con-
centrations resulted in a decreased cortisol response to
LPS.2 Additionally, Curley et al. observed a blunted
cortisol response to both corticotropin releasing hor-
mone and ACTH challenges in temperamental beef hei-
fers,16 which had greater cortisol concentrations prior
to administration of the challenges.
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The release of cytokines, stimulated by pathogen-
activated immune cells and cortisol, stimulates cells of
the innate immune response and subsequently results in
acute-phase protein production and adaptive immune
system activation. Concentrations of cytokines
remained low during the Baseline and Infusion periods
prior to LPS administration. While there was no influ-
ence of treatment on post-LPS concentrations of TNF-
a or IFN-g, infusion of Intralipid or administration of a
Dextrose bolus prior to LPS administration did
decrease post-LPS concentrations of IL-6. This sug-
gests that an increase in energy availability was able
to reduce the IL-6 response to LPS. While no literature
is available in cattle, a study in humans observed that
administration of IL-6 increased circulating glucose
concentrations.17 Additionally, Helge et al. reported a
relationship between IL-6 concentrations and glucose
homeostasis in humans during exercise.18 These studies
suggest that a relationship exists between glucose and
IL-6 concentrations such that IL-6 may serve as a cata-
bolic agent that increases available glucose. It is pos-
sible that the administration of the Dextrose bolus
increased energy availability, or increased the sum of
energy available, thus alleviating the need for the steers
to break down additional energy stores, resulting in a
decrease in IL-6 concentrations. However, further
research is warranted in order to fully understand the
relationship between energy stores and IL-6 concentra-
tions in cattle.
Greater concentrations of cortisol prior to the LPS
challenge in the Lipid steers may explain, in part, the
decreased post-LPS concentrations of IL-6, as cortisol
can negatively influence pro-inflammatory cytokines.
However, cortisol concentrations were not different
between Control and Dextrose steers; therefore, corti-
sol alone does not explain the decreased IL-6 response
to LPS in the Dextrose-treated steers. This suggests that
differences in energy availability may have had a
greater influence on the cytokine response to LPS
than cortisol or other factors. Additionally, a decreased
inflammatory response may be beneficial, as it can
allow for a quicker return to homeostasis; whereas an
extended and prolonged inflammatory response can
cause more damage to healthy tissues, delaying recov-
ery. While it is not completely clear from the current
study whether or not the decreased pro-inflammatory
cytokine response observed in Dextrose and Lipid
steers is beneficial to the overall health and recovery
of the steers, it does warrant further investigation.
Fatty acids are considered important modulators of
inflammation. As discussed above, NEFAs can be used
as an energy source, and can be readily available for use
by tissues within the body.19 Additionally, the incorpor-
ation of different fatty acids into the plasma membrane
can result in various effects on cellular function, including
modulation of gene expression through altering receptor
binding, intracellular signaling and transcription
factors,20 thus influencing how cells respond to a patho-
gen challenge. Binding of fatty acids to peroxisome pro-
liferator-activated receptor-g, specifically
polyunsaturated fatty acids, can result in down-regula-
tion or suppression of inflammation.20 As the fatty acid
composition of Intralipid is mainly polyunsaturated fatty
acids, the results from the current study support previous
data regarding the potential anti-inflammatory effect of
NEFAs on the pro-inflammatory response.
There are numerous studies describing the effects of
elevated concentrations of free fatty acids on compo-
nents of the immune response in cattle, mainly in
periparturient dairy cows, which display similar meta-
bolic profiles as temperamental cattle. Peripheral
blood mononuclear cells isolated from pregnant
dairy cows and incubated with various concentrations
of NEFA (0.25–2.00mmol/l) found a decrease in the
production of IgM, as well as IFN-g,21 demonstrating
that NEFA can influence in vitro lymphocyte function.
Similarly, production of IFN-g by isolated leukocytes
was decreased in dairy cows classified to have fat
mobilization syndrome.22 Ster et al. reported a
decrease in the production of IFN-g by isolated
dairy cow peripheral blood mononuclear cells when
incubated with high concentrations of NEFA.23
These data suggest that greater concentrations of
NEFA negatively affect the adaptive immune
response, as IFN-g is known to stimulate the adaptive
immune response. Specifically, IFN-g is responsible
for driving differentiation of T cells during leukocyte
antigen presentation. In the current study, there were
no differences in IFN-g concentrations between treat-
ments; however, the lack of significant differences may
be due to animal-to-animal variation between steers.
Additionally, the studies by Lacetera et al. and Ster
et al. only measured IFN-g.21,23 Therefore, it is
unclear whether there were differences in other cyto-
kines, such as TNF-a and IL-6.
There are data in cattle on the effect of endogenous
NEFAs on the pro-inflammatory response, yet fewer
data on the use of exogenously administered Lipid
emulsions on the pro-inflammatory response. A study
in humans demonstrated that Intralipid decreased ex
vivo cytokine production induced by endotoxin in
human whole blood, but failed to alter in vivo cytokine
production when endotoxin was administered in the
middle of a 4-h Intralipid infusion.24 Yet another
study by Krogh-Madsen et al. reported an increase in
pro-inflammatory cytokines in response to endotoxin
challenge in Intralipid-infused humans.25 However, stu-
dies in rodents have observed that increases in trigly-
cerides and lipoproteins can improve survival when
challenged with endotoxin.26 Therefore, there are
apparent differences in the effects of exogenously-admi-
nistered Lipids on the inflammatory responses across
mammalian species which emphasizes the need for fur-
ther investigation in this area.
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Conclusion
This study demonstrated that infusion of an exogen-
ous Lipid emulsion (i.e. Intralipid) can increase circu-
lating NEFA and Baseline cortisol concentrations of
Holstein steers to values similar to what has been
observed in temperamental beef bulls. Additionally,
administration of Dextrose immediately prior to LPS
administration decreased the RT response to LPS
challenge. Furthermore, infusion of Intralipid
decreased the IL-6 and cortisol responses to LPS chal-
lenge. To our knowledge, these are the first data to: 1)
suggest that exogenous administration of a Lipid
emulsion can increase circulating NEFA concentra-
tions that may modulate the innate immune response
in cattle, and 2) suggest that greater circulating NEFA
concentrations observed in temperamental cattle may
be responsible for the altered pro-inflammatory
response reported following an LPS challenge.
Further research is necessary in order to understand
the mechanisms behind the altered pro-inflammatory
response to LPS challenge in the presence of greater
circulating NEFA concentrations, and if the observed
differences stemming from Lipid infusion would
expedite the return to homeostasis.
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